Our Pricing

How to Save on Mounjaro Weight Loss Treatment in the UK

Published on: June 03, 2026

Searching for a valid mounjaro discount code uk offer? At Cured Pharmacy, new patients can save £20 on their first Mounjaro prescription using code WEIGHTLOSSNEW, with transparent pricing from £124.99 and a free clinical consultation by UK-registered prescribers. This guide explains how Mounjaro works, what you can expect to pay, and how our discount programme helps make this advanced weight loss treatment more accessible.

Understanding Mounjaro and Tirzepatide

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike older single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing more pronounced effects on appetite regulation and metabolic control.

In the SURMOUNT-1 clinical trial, participants receiving the 15mg tirzepatide dose achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% in the placebo group [1]. This dual-receptor mechanism helps patients feel fuller for longer whilst improving insulin sensitivity and reducing food cravings throughout the day.

Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device. Treatment typically begins at a lower dose of 2.5mg, with gradual increases every four weeks to minimise gastrointestinal side effects whilst allowing your body to adjust to the medication [2].

Mounjaro Pricing and How Our Discount Code Works

At Cured Pharmacy, Mounjaro pricing starts from £124.99 per month, with the final cost determined by your prescribed dose following clinical assessment. Our transparent pricing model means you'll see the exact cost before completing your online consultation, with no hidden fees or surprise charges at checkout.

New patients can apply the discount code WEIGHTLOSSNEW at checkout to receive £20 off their first Mounjaro prescription. This voucher code is applied automatically during payment and reduces your initial treatment cost, making it more affordable to begin your weight management journey with tirzepatide therapy.

Unlike some online pharmacies that advertise low headline prices but add consultation fees or delivery charges later, our pricing includes your UK prescriber assessment, medication dispensing by our GPhC-registered pharmacy team, and discreet next-day delivery across the UK. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all dispensing to ensure you receive genuine UK-licensed medication.

What's Included in Your Mounjaro Service

Your Mounjaro prescription through Cured Pharmacy includes a comprehensive clinical assessment by a UK-registered prescriber, who will review your medical history, current medications, and weight management goals. The consultation typically takes under three minutes to complete online and determines your suitability for tirzepatide treatment.

Once approved, your medication is dispensed from our GPhC-registered pharmacy and delivered in 100% discreet packaging with no external branding. Follow-up prescriptions are managed through your patient account, with ongoing prescriber support available throughout your treatment journey.

Comparing Mounjaro to Other Weight Loss Treatments

Several prescription weight loss medications are available through UK pharmacies, each working through different mechanisms to support weight management. Mounjaro's dual-receptor action distinguishes it from single-pathway GLP-1 treatments, though individual response varies based on metabolic factors and lifestyle adherence.

Wegovy contains semaglutide, a GLP-1 receptor agonist that demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial [3]. Whilst effective for many patients, the single-receptor mechanism typically produces less pronounced weight reduction compared to tirzepatide's dual action. Saxenda uses liraglutide, an earlier-generation GLP-1 medication requiring daily injections rather than weekly administration.

Oral medications such as Orlistat work through a completely different mechanism, blocking approximately 30% of dietary fat absorption in the digestive system [4]. Mysimba combines naltrexone and bupropion to reduce appetite through central nervous system pathways. Your UK prescriber will recommend the most appropriate treatment based on your medical history, weight loss goals, and any contraindications identified during assessment.

Which Treatment Offers the Best Value?

Treatment value depends on both clinical effectiveness and cost-effectiveness for your individual circumstances. Whilst Mounjaro typically costs more per month than oral alternatives, the superior weight loss outcomes demonstrated in clinical trials may represent better long-term value for patients seeking significant weight reduction. Injectable treatments also eliminate the need for multiple daily doses, improving adherence for many patients.

Our UK prescribers consider both clinical suitability and patient preference during consultation. Some patients prefer starting with more affordable options such as Orlistat before progressing to injectable treatments, whilst others prioritise the convenience and efficacy of once-weekly injections from the outset.

Clinical Evidence and Expected Results

The SURMOUNT clinical trial programme provides the most comprehensive evidence for tirzepatide's efficacy in weight management. Across multiple studies involving over 5,000 participants, tirzepatide consistently outperformed placebo and active comparators in producing clinically significant weight loss [1][5].

In SURMOUNT-1, 89% of participants receiving the 15mg dose achieved at least 5% body weight reduction, with 57% achieving 20% or greater weight loss over 72 weeks [1]. These results represent substantially higher response rates compared to lifestyle modification alone, which typically produces 3-5% weight loss in clinical trials.

Beyond weight reduction, tirzepatide treatment improved multiple cardiometabolic markers including blood pressure, lipid profiles, and glycaemic control in participants with prediabetes [5]. However, individual results vary considerably based on adherence to dietary modifications, physical activity levels, and metabolic factors. Your UK prescriber will discuss realistic expectations during your clinical assessment.

Managing Side Effects and Treatment Safety

The most common side effects associated with Mounjaro are gastrointestinal symptoms including nausea, diarrhoea, constipation, and reduced appetite [2]. These effects typically occur during dose escalation and diminish as your body adjusts to the medication. Starting at the lowest dose and increasing gradually every four weeks helps minimise these symptoms.

Approximately 10-15% of trial participants experienced nausea during the initial treatment phase, though fewer than 5% discontinued treatment due to gastrointestinal side effects [1]. Eating smaller, more frequent meals and avoiding high-fat foods can help manage digestive symptoms during the adjustment period.

Serious side effects are rare but require immediate medical attention. These include signs of pancreatitis (severe abdominal pain), gallbladder problems, severe allergic reactions, or symptoms of thyroid tumours. Mounjaro carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though human relevance remains unclear [2]. Your prescriber will screen for contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 before prescribing.

Who Should Not Use Mounjaro

Mounjaro is contraindicated in patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or previous serious hypersensitivity to tirzepatide. It should not be used during pregnancy or breastfeeding, and women of childbearing potential should use effective contraception during treatment [2].

Your UK prescriber will assess your full medical history during consultation, including any history of pancreatitis, severe gastrointestinal disease, diabetic retinopathy, or kidney problems. Certain medications may interact with Mounjaro, particularly insulin and sulfonylureas, requiring dose adjustments to prevent hypoglycaemia.

Getting Started with Mounjaro at Cured Pharmacy

Beginning your Mounjaro treatment through Cured Pharmacy starts with a free online consultation that takes under three minutes to complete. You'll answer questions about your medical history, current medications, weight management goals, and any previous weight loss treatments you've tried. This information allows our UK-registered prescribers to determine whether Mounjaro is clinically appropriate for your circumstances.

If approved, you'll select your preferred delivery option and apply the discount code WEIGHTLOSSNEW at checkout to receive your new patient discount. Your medication is dispensed from our GPhC-registered pharmacy (registration number 9012511) and delivered in discreet packaging with no external branding indicating the contents.

Your first prescription typically covers a four-week supply at the starting dose of 2.5mg once weekly. Follow-up prescriptions allow for dose escalation according to the licensed titration schedule, with ongoing prescriber support available through your patient account. Most patients reach their maintenance dose within 16-20 weeks, after which monthly prescriptions continue at the effective dose determined by your prescriber and treatment response.

Ongoing Support and Prescription Management

Successful weight management with Mounjaro requires ongoing monitoring and support beyond the initial prescription. Our clinical team provides prescription refill reminders, dose adjustment guidance, and access to prescriber consultations if you experience side effects or have questions about your treatment.

Your patient account allows you to manage repeat prescriptions, update delivery addresses, and track your treatment progress. We recommend combining Mounjaro with sustainable dietary modifications and increased physical activity for optimal results, as clinical trials demonstrate superior outcomes when medication is paired with lifestyle changes [5].

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines.org.uk. Retrieved from https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2014). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. Retrieved from https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. Garvey, W. T., Frias, J. P., Jastreboff, A. M., et al. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613-626. https://doi.org/10.1016/S0140-6736(23)01200-X [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to dietary modifications and lifestyle changes alongside medication therapy.